Skip navigation
Quote
|
Chart
Symbol Lookup
All CNBC
|
News
|
Video
Register
Sign In
Member Center
Sign Out
HOME
NEWS
MARKETS
EARNINGS
INVESTING
VIDEO
CNBC TV
CNBC PLUS
CONTEST
HOME
NEWS
MARKETS
EARNINGS
INVESTING
VIDEO
CNBC TV
CNBC PLUS
CONTEST
Register
Sign In
Member Center
Sign Out
U.S.
Asia-Pacific
Europe
Energy
Green
Politics
Technology
Blogs
Wires
Slideshows
Special Reports
Corrections
Company: Genentech, Inc.
POSTS
VIDEO
NEWS
Genentech, Inc. :
DNA
loading...
Quote
|
Chart
|
News
|
Profile
[
DNA
Loading...
(
)
]
Breaking News: DNA
Roche sued over its offer for Genentech, with CNBC's Mike Huckman
Roche's Play for DNA
Drugmaker Roche offers to acquire all outstanding Genentech shares, with Franz Humer, Roche chairman
Cramer on Biotech
An outlook on the biotech sector, with Mad Money host Jim Cramer.
Word on the Street
The Fast Money guys take a look at today's top business stories.
Investing in Drug Stocks
A look at whether the sector should be apart of your portfolio, with Catherine Arnold, Credit Suisse and Damien Conover, Morningstar
What's Genentech Worth?
Roche will have to up its offer price in order to buy Genentech, but it's tough to speculate on what the right price is, Christophe Eggmann ...
Another Overseas Offer
Swiss drug giant Roche makes a play for all of Genentech and a look at earnings for the pharma sector, with CNBC's Mike Huckman
Roche/Genentech Deal
Roche offers to buy the rest of Genentech for $43.7B, reports CNBC's David Faber
Roche's Offer a 'Good Deal'
Roche's offer to buy out Genentech appears to be a good deal, financially and pharmaceutically, according to Dr. Keither Schlagbauer from Fr...
Roche Offer Too Low?
Genentech shareholders probably won't be too happy with the bid price from Roche and there might be higher offers to come, Birgit Kulhoff fr...
Roche Bid: Why Now?
Swiss drugmaker Roche Holding offered to buy all the outstanding shares in its US partner Genentech Monday. Peter McDougall, CEO of Druganal...
Roche Offers $43.7 Billion for Genentech
Roche offered to buy all outstanding shares in Genentech for $43.7 billion Monday. Franz B. Humer, chairman of Roche, discusses the deal.
Friday Trade
Preparing your portfolio for next week, with Steve Grasso, Stuart Frankel and John O'Donoghue, Cowen & Co.
CNBC Investor Network
Peter Stock, president & CIO of Stock Investment Management Inc
Tomorrow's Trades #3
In search of a bear market band-aid, with Kris Jenner, T. Rowe Price Health Sciences Fund portfolio manager and the Fast Money traders.
Regenerating Genentech
A look at the pharmaceutical company's earnings and performance of its cancer drug, with CNBC's Mike Huckman
Genentech Earnings
A look at the biotech company's Q2 results, with Christopher Raymond, Robert W. Baird & Co. senior biotech analyst
Word on the Street
The Fast Money guys take a look at today's top business stories.
Genentech Q2 Earnings
Analysis of Genentech's Q2 results, with CNBC's Mike Huckman
Recession Guide: CR Bard
Cramer believes the way to make money in this market is with healthcare stocks. He has recommended five this week: Genentech, Smith and Neph...
Next
1
2
Posts | COMPANY : Genentech, Inc.
21 Jul 2008
Who's Next After Genentech?
Posted By:
Tom Brennan
|
Mad Cap Recap
Cramer ventures a guess as to who's next on the takeover list....
Read
More
21 Jul 2008
Oil Rebounds Off 6-Week Low
Posted By:
Lee Brodie
|
Word on the Street
With so much news Monday we need two "Word on the Street" posts...
Read
More
21 Jul 2008
What's Genentech Really Worth?
Posted By:
Geoff Cutmore
|
Morning Thoughts - Geoff Cutmore
You have to wonder at markets and analysts for that matter...
Read
More
21 Jul 2008
Are Banks Overbought?
Posted By:
Bob Pisani
|
Trader Talk with Bob Pisani
Bank of America made it four in a row with big banks beating expectations, and beating big: $0.72 is 40 percent higher than the $0.53 expected...
Read
More
15 Jul 2008
Bear Market Band-Aid
Posted By:
Lee Brodie
|
Tomorrows Playbook
You’ve gotta’ love modern medicine...
Read
More
More Posts
News | COMPANY : Genentech, Inc.
Law firm sues Roche, calls Genentech bid too low
Source:
The Associated Press
Genentech shareholders sue over Roche bid
Source:
Reuters
Genentech shareholders sue over Roche bid
Source:
Reuters
Fitch may lower Roche rating due to Genentech bid
Source:
The Associated Press
Top drug companies' earnings beat forecasts
Source:
Reuters
Top drug companies' earnings beat forecasts
Source:
Reuters
Roche gets Arius in biotech buying moves
Wednesday, 23 Jul 2008
Source:
The Associated Press
Top Roche, Genentech officials meeting
Tuesday, 22 Jul 2008
Source:
The Associated Press
Biogen Idec's 2Q profit rises 11 percent
Tuesday, 22 Jul 2008
Source:
The Associated Press
Moody's considers downgrading Genentech ratings
Tuesday, 22 Jul 2008
Source:
The Associated Press
More News
POPULAR TAGS
More:
Topics
|
Sectors
|
Companies
TOPICS
More
Current DateTime: 05:24:02 24 Jul 2008
LinksList Documentid: 23188555
Energy
Economy
Housing
Stock Market
Stock Picks
SECTORS
More
Current DateTime: 05:24:53 24 Jul 2008
LinksList Documentid: 23188557
Financial Services
Health Care
Oil & Gas
Retail
Technology
Stay up to date with our
COMPANY:
Inc. Genentech
RSS feed
We'll send the latest COMPANY: Inc. Genentech information to you
Subscribe to this RSS feed
How to use RSS?
HOME
|
NEWS
|
MARKETS
|
EARNINGS
|
INVESTING
|
VIDEO
|
CNBC TV
|
CNBC PLUS
|
CNBC HD+
About CNBC
|
Site Map
|
Privacy Policy
|
Terms of Service
|
Advertise
|
Help
|
Feedback
|
Video Reprints
Partners:
AOL Money
|
BloggingStocks.com
(c) 2008 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
U.S.
Asia-Pacific
Europe
Energy
Green
Politics
Technology
Blogs
Wires
Slideshows
Special Reports
Corrections
Markets Front
Pre-Markets
Stocks
Bonds
Funds
Currencies
Futures
Economy
World
Contest
Earnings Front
News
Calendar
Surprises
Highlights
Ideas
Picks & Pans
Personal Finance
Portfolio Watchlist
Stock Screener
Fund Screener
Earnings Screener
Latest Video
Top Video
US Video
Europe Video
Asia Video
CEO Interviews
Analyst Interviews
CNBC PLUS
CNBC U.S.
CNBC Asia Pacific
CNBC Europe
CNBC World
CNBC HD+